⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer

Official Title: A Phase II, Open-Label Study of Ispinesib in Subjects With Locally Advanced or Metastatic Platinum-Refractory or Platinum-Relapsed Non-Small Cell Lung Cancer (NSCLC)

Study ID: NCT00085813

Interventions

Ispinesib

Study Description

Brief Summary: This study was designed to determine how effective and safe Ispinesib is in treating locally advanced or metastatic Non-small Cell Lung cancer in patients who have received a platinum-based chemotherapy and whose disease continues to progress. Treatment involves a 1-hr treatment given intravenously (IV), repeated once every 21 days. A patient may continue treatment as long as they are benefiting from the treatment. Blood samples will be taken at specific times over 24 hr period to measure the amount of drug in your body at specific times after the drug is given. Blood samples will also be taken for routine lab tests such as complete blood counts and clinical chemistries. Physical exams will be performed before each treatment.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

GSK Investigational Site, Scottsdale, Arizona, United States

GSK Investigational Site, Jacksonville, Florida, United States

GSK Investigational Site, Rochester, Minnesota, United States

GSK Investigational Site, Rochester, New York, United States

GSK Investigational Site, Greensboro, North Carolina, United States

GSK Investigational Site, Philadelphia, Pennsylvania, United States

GSK Investigational Site, Memphis, Tennessee, United States

GSK Investigational Site, Bruxelles, , Belgium

GSK Investigational Site, Edegem, , Belgium

GSK Investigational Site, Leuven, , Belgium

GSK Investigational Site, Sutton, Surrey, United Kingdom

Contact Details

Name: GSK Clinical Trials, MD

Affiliation: GlaxoSmithKline

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: